Company Filing History:
Years Active: 1987-1990
Title: The Innovations of Roger J Watson
Introduction
Roger J Watson is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of virology, particularly in the development of methods for producing herpes simplex viral proteins. With a total of 3 patents to his name, Watson's work has implications for vaccine development against herpes simplex virus infections.
Latest Patents
Watson's latest patents focus on the production of herpes simplex viral proteins. One of his patents describes methods and compositions for the cloning and expression of the Herpes Simplex Virus (HSV) glycoprotein (gD) gene in single-cell host organisms. This innovation includes methods for culturing these organisms to produce HSV-gene products. The HSV gD-related polypeptides produced through these recombinant DNA techniques may be formulated as immunogens in vaccines to protect against HSV-1 and HSV-2 infections. Another patent similarly outlines methods for cloning and expressing the HSV glycoprotein (gD) gene, emphasizing its potential use in vaccine formulations.
Career Highlights
Throughout his career, Watson has worked with prominent organizations, including American Cyanamid Company and Molecular Genetics Research and Development Limited Partnership. His experience in these companies has contributed to his expertise in genetic research and development.
Collaborations
Watson has collaborated with notable individuals in his field, including Lynn W Enquist and Henry J George. These collaborations have likely enriched his research and innovation efforts.
Conclusion
Roger J Watson's contributions to the field of virology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in vaccine development against herpes simplex virus infections.